Gynecologic Cancer
Conference Coverage
Neoadjuvant chemotherapy induces mutational, molecular shifts in ovarian cancers
NATIONAL HARBOR, MD. – Neoadjuvant chemotherapy was associated with changes in gene expression and associated pathways in high-grade serous...
Gynecologic Oncology Consult
Risk for obstetric complications when treating cervical dysplasia
Consider recommending a 12-month interval between treatment and pregnancy to ensure resolution of high-grade dysplasia.
Conference Coverage
VIDEO: When early-stage vulvar cancer recurs, the prognosis is poor
Incidence and death rates for vulvar cancer are rising.
Conference Coverage
VIDEO: How to start an oncology sexual health clinic
NATIONAL HARBOR, MD – Start small, but anticipate growth. Engage your administration from the start. Be smart about resources, and consider using...
Conference Coverage
VIDEO: Sex, intimacy part of history in gynecologic oncology care
NATIONAL HARBOR, MD. – Understanding a patient’s sexual history and assessing how a gynecologic malignancy has affected that patient’s sexual...
Conference Coverage
Video: Try ‘PLISSIT’ to address postcancer sexual health
NATIONAL HARBOR, MD. – Comprehensive care of patients with gynecologic malignancies should include a sensitive and thorough assessment of sexual...
Conference Coverage
Study supports NCCN recommendations on risk-reducing salpingo-oophorectomy
A large hereditary cancer study supports National Comprehensive Cancer Network guidance to consider risk-reducing salpingo-oophorectomy (RRSO)...
From the Journals
Laparoscopic and abdominal hysterectomy yield equivalent survival
A randomized trial suggests that long-term survival outcomes are just as good with total laparoscopic hysterectomy as with total abdominal...
News
PARP inhibitor approved as maintenance for recurrent ovarian cancer
The indication does not require a suspected or confirmed deleterious BRCA mutation.
Conference Coverage
Complete resection tied to improved survival in low-grade serous ovarian cancer
Unlike platinum-based chemotherapy, resection to the point of no residual disease was associated with improved survival.
Conference Coverage
Adding Pap to plasma testing boosted detection of ovarian tumors
NATIONAL HARBOR, MD – Combination is “a promising step toward a broadly applicable screening methodology for the early detection of ovarian cancer...